Biocon Shares News

Markets

Why investors are questioning logic behind Biocon Biologics deal value

Shares of Biocon lost nearly 6% since it announced the stake saleBiocon Biologics has been valued at three times forward revenues, which some feel is below par

1 min read7 Jan 2020
Companies

Biocon sells 1.88% stake in Syngene for Rs230 crore

Syngene International promoter Biocon says it has sold 37,65,574 equity shares of Syngene amounting to 1.88% through open market sale

1 min read18 May 2018
Market

Biocon shares fall over 5% after US, European regulators issue observations

Biocon shares decline 5.53% to Rs626.80 per shares on BSE after the USFDA and a European regulator issued observations after inspection of its facility in Bengaluru

1 min read3 May 2018
Industry

Biocon sees approvals unlocking $1 billion biosimilar sales

Three more approvals Biocon now expects this year in the US and Europe would expand its presence in the pioneering field of biosimilars

2 min read20 Mar 2018
Companies

Biocon gets 6 observations from USFDA for Malaysia facility

Biocon says USFDA has completed a pre-approval inspection of its manufacturing facility in Malaysia and issued a Form 483 with six observations

1 min read21 Feb 2018
Market

Opening bell: Asian markets open lower; telcos, Shalby IPO in news

In other news, Hines will invest $23 million in Tata Housing Development's premium wellness-themed project Serein at Thane in Maharashtra

1 min read5 Dec 2017
Market

Biocon shares ends 15% higher on USFDA approval for Herceptin biosimilar

Biocon shares jump 16.33% to Rs519.50 as partner Mylan NV receives approval from the USFDA for its biosimilar for Roche's drug Herceptin

1 min read4 Dec 2017
Companies

Biocon shares rise 7% after Bengaluru unit gets US FDA clearance

Biocon's Bengaluru unit, which had received observations relating to lapses in quality compliance earlier this year, has been cleared by the US FDA

2 min read20 Nov 2017
Industry

Biocon-Mylan resubmit applications for 2 biosimilars in Europe

Biocon has also filed applications for biosimilars trastuzumab and pegfilgrastim with the US Food and Drug Administration

2 min read7 Nov 2017
Companies

USFDA seeks more data on Biocon-Mylan’s biosimilar

USFDA issues complete response letter for Biocon and Mylan’s application for biosimilar pegfilgrastim seeking certain data before the product gets an approval

1 min read10 Oct 2017
Load More

Popular Topics

Budget

The Union Budget contains details about the estimated receipts and the expenditure of the government for a particular fiscal year. The Budget is allotted for the upcoming fiscal year, which runs from 1st April to 31st March of the next year. Here is a quick guide on how the Union Budget is prepared

25 Articles

ICICI Bank

Shares of ICICI Bank had a drop of -0.45% to Rs. 852.05 at closing today.

2 Articles